Similarly, TRIM24 can increase both PIK3CA and EGFR levels in human prostate cancer cell lines (LNCaP, PC-3, and C4-2), thereby facilitating the activation of the PI3K/AKT signaling pathway. This evidence concerns the gene TRIM24 and prostate carcinoma.